Journal article Published 2022

Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration

J. Leischner Fialova, K. Honigova, M. Raudenska, L. Miksatkova, R. Zobalova, J. Navratil, J. Smigova, T. Ramji Moturu, T. Vicar, J. Balvan, K. Vesela, N. Abramenko, Z. Kejik, R. Kaplanek, J. Gumulec,

Show all 21 authors

D. Rosel, P. Martasek, J. Brabek, M. Jakubek, J. Neuzil, M. Masarik

Biomedicine & Pharmacotherapy 154, 113582 (2022)

View on PubMed Cite

2022 Year
36055111 PMID

Cite this publication

LEISCHNER FIALOVA, J., K. HONIGOVA, M. RAUDENSKA, L. MIKSATKOVA, R. ZOBALOVA, J. NAVRATIL, J. SMIGOVA, T. RAMJI MOTURU, T. VICAR, J. BALVAN, K. VESELA, N. ABRAMENKO, Z. KEJIK, R. KAPLANEK, J. GUMULEC, D. ROSEL, P. MARTASEK, J. BRABEK, M. JAKUBEK, J. NEUZIL, M. MASARIK: Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration. Biomedicine & Pharmacotherapy. 2022, 154, 113582, ISSN: 0753-3322, PMID: 36055111.

Cite this publication

Details